Fidelity Investments’s DermTech, Inc. Common Stock DMTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,927
Closed -$1.35K 5701
2024
Q1
$1.35K Sell
1,927
-23,267
-92% -$26.3K ﹤0.01% 4754
2023
Q4
$44.1K Buy
25,194
+2,062
+9% +$3.01K ﹤0.01% 3570
2023
Q3
$33.3K Sell
23,132
-3,661
-14% -$9.16K ﹤0.01% 3554
2023
Q2
$69.7K Sell
26,793
-438
-2% -$1.31K ﹤0.01% 3301
2023
Q1
$100K Buy
27,231
+599
+2% +$2.52K ﹤0.01% 3207
2022
Q4
$47.1K Buy
26,632
+26,461
+15,474% +$70.4K ﹤0.01% 3458
2022
Q3
$1K Sell
171
-2,174
-93% -$13.4K ﹤0.01% 4770
2022
Q2
$13K Sell
2,345
-988
-30% -$8.09K ﹤0.01% 4038
2022
Q1
$49K Buy
+3,333
New +$44.6K ﹤0.01% 3694
2021
Q4
Sell
-11
Closed 5058
2021
Q3
$0 Buy
11
+10
+1,000% +$351 ﹤0.01% 5172
2021
Q2
$0 Sell
1
-28
-97% -$1.15K ﹤0.01% 5018
2021
Q1
$1K Buy
+29
New +$1.52K ﹤0.01% 3905

Other funds holding DMTK

Fidelity Investments's DMTK Position: Q2 2024 in Review

Fidelity Investments sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2024, closing a stake of 1,927 shares — an estimated $1.35K sold.

Fidelity Investments first reported a position in DMTK in Q1 2021 and held it in 12 quarters. The position peaked at $100K in Q1 2023. 8 funds tracked by Wall St. Rank hold DMTK as of Q2 2024.

  • Fidelity Investments reported no remaining DermTech, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Fidelity Investments sold 1,927 DermTech, Inc. Common Stock shares in Q2 2024, an estimated $1.35K.
  • Fidelity Investments first reported a position in DermTech, Inc. Common Stock in Q1 2021 and held it in 12 quarters.
  • Fidelity Investments's DermTech, Inc. Common Stock position peaked at $100K in Q1 2023.
  • 8 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2024.

Based on Fidelity Investments's 13F filing for Q2 2024, filed 13 Aug 2024.